This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Winners & Losers: MoneyGram International

Citigroup (C - Get Report), ravaged by its exposure to subprime mortgages, wrote down a pretax sum of $18.1 billion and took a fourth-quarter loss of $9.83 billion, or $1.99 a share. That reverses last year's profit of $5.13 billion, or $1.03 a share, and it compares with Wall Street targets for a loss of $1.03 a share, per Thomson Financial. Revenue plummeted 69.7% to $7.22 billion, also thanks to the massive subprime writedowns.

Citi shares were recently sliding $2.26, or 7.8%, to $26.80, in sharp retreat from the upward float they had enjoyed over the past week.

On the uptick, Arena Therapeutics (ARNA - Get Report) picked up $1.14, or 15%, to $8.55, after an upgrade from Bank of America analyst William Ho. He raised his rating on the stock to buy from neutral, predicting that a data safety monitoring committee reviewing echocardiograms won't find a link between Arena's obesity drug Lorcaserin and heart valve damage.

Elsewhere, Lifecore Biomedical (LCBM) said Tuesday that it will be acquired by Warburg Pincus for $17 a share in cash, a 30% premium over the average price of the shares for the last 30 days, valuing the company at about $239 million. The company expects the transaction will close before the end of the first quarter. Shares climbed $3.89, or 30.3%, to $16.73.

Back in earnings, Boston bank State Street (STT - Get Report) said fourth-quarter income sank 27.8% year over year to $223 million, 57 cents a share. As previously disclosed , that's primarily because the Boston bank set aside 71 cents a share for covering potential legal costs related to losses from its mortgage-backed investments. Even excluding that one-off expense, however, the bank still came in 7 cents shy of the $1.35 per-share analyst consensus. Shares surrendered 6.1% to $79.70 in recent trading.

Shares of Minneapolis-based money-transfer and payment-processing servicer MoneyGram International (MGI - Get Report) were cut in half, down 50.7% at $6. The company announced late Monday that, from Sept. 30 to Nov. 30, its investment portfolio lost an unrealized $571 million, bringing total losses to $860 million. MoneyGram is negotiating with Thomas H. Lee Partners for a cash injection of about $800 million. Under the proposed deal, Thomas H. Lee Partners would control between 60% and 65% of MoneyGram.

Also losing ground was Memsic (MEMS), shares of which ceded 19.4% to $6.78. The Andover, Mass., provider of semiconductor and systems solutions exercised its overallotment option to buy 823,000 shares of its stock at $10 a share, the price at the company's IPO, less underwriting discounts and commissions.
This article was written by a staff member of

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MEMS $0.00 0.00%
ARNA $1.58 -0.32%
C $44.23 -0.96%
MGI $6.00 1.18%
STT $59.74 -0.47%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs